𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Erratum: Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome

✍ Scribed by Paolo Comeglio; Alison L. Evans; Glen W. Brice; Anne H. Child

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
149 KB
Volume
18
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis

Marfan syndrome (MFS), an autosomal dominant disorder of the extracellular matrix, is due to mutations in fibrillin-1 (FBN1) gene. Investigations carried out in the last decade, unveiled the unpredictability of the site of the mutation, which could be anywhere in the gene. FBN1 mutations have been reported in a spectrum of diseases related to MFS, with no clear evidence for a phenotype-genotype correlation. In this paper we analysed 10 British patients affected by MFS and we were able to characterise five novel missense mutations (C474W, C1402Y, G1987R, C2153Y, G2536R), one novel frameshift mutation (7926delC), one already described mutation (P1424A) and one FBN1 variant (P1148A) classified as a polymorphism in the Asian population. Four out of the five novel missense mutations involved either cysteines or an amino acid conserved in the domain structure. The mutation yield in this study is calculated at 80.0% (8/10), thus indicating that SSCA is a reliable and cost-effective technique for the screening of such a large gene. Our results suggest that this method is reliable to search for FBN1 mutations and that FBN1 screening could be a helpful tool to confirm and possibly anticipate the clinical diagnosis in familial cases.

πŸ“œ SIMILAR VOLUMES

Detection of six novel FBN1 mutations in
Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome
✍ Paolo Comeglio; Alison L. Evans; Glen W. Brice; Anne H. Child πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

Marfan syndrome (MFS), an autosomal dominant disorder of the extracellular matrix, is due to mutations in fibrillin-1 (FBN1) gene. Investigations carried out in the last decade, unveiled the unpredictability of the site of the mutation, which could be anywhere in the gene. FBN1 mutations have been r

Detection of thirty novel FBN1 mutations
Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy
✍ Andrew Biggin; Katherine Holman; Maggie Brett; Bruce Bennetts; Lesley AdΓ¨s πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 49 KB πŸ‘ 2 views

Marfan syndrome (MFS) is a disorder of the extracellular matrix caused by mutations in the gene encoding fibrillin-1 (FBN1). Recent studies have illustrated the variability in disease severity and clinical manifestations of MFS. Useful genotype-phenotype correlations have been slow to emerge. We scr

Identification of 9 novel FBN1 mutations
Identification of 9 novel FBN1 mutations in German patients with Marfan syndrome
✍ Alice Abd El-Aleem; Matthias Karck; Axel Haverich; JΓΆrg Schmidtke; Mine Arslan-K πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 20 KB πŸ‘ 2 views

We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by

Identification of 29 novel and nine recu
Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype–phenotype correlations in 76 patients with Marfan syndrome
✍ Kathrin Rommel; Matthias Karck; Axel Haverich; Yskert von Kodolitsch; Meike Rybc πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Communicated by Jurgen Horst Marfan syndrome (MFS) is an autosomal-dominant disorder of the fibrous connective tissue that is typically caused by mutations in the gene coding for fibrillin-1 (FBN1), a major component of extracellular microfibrils. The clinical spectrum of MFS is highly variable